Since the commercial development of therapeutic monoclonal antibodies commenced in the early 1980s, the monoclonal antibodies have grown to become the most successful class of biotech drugs for the diagnosis and treatment against various diseases and infections. Besides the traditional IgG antibody, Creative Biolabs can help to develop Non-IgG therapeutic antibodies for our customers all over the world. Learn more: iga services